- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
CMS’ proposal to make Part D plans subtract pharmacy fees from drug prices at the point-of-sale would increase drug costs for one-third of beneficiaries and decrease costs for another third of beneficiaries, according to a study by Milliman that was paid for by the Pharmaceutical Care Management Association.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us